Literature DB >> 7627484

Vertebral fractures in men and women: how discriminative are bone mass measurements?

A Stewart1, D Felsenberg, L Kalidis, D M Reid.   

Abstract

Vertebral fractures are associated with osteoporosis. This study examined men and women with vertebral deformation/fractures, as defined by vertebral morphometry. These were compared with a population derived group measured contemporaneously who were defined as having no vertebral deformation/fracture by the radiographs. All patients underwent a dual energy X-ray absorptiometry (DXA) scan of the spine and hip, and a broadband ultrasound attenuation (BUA) scan of their os calcis. The abilities of these two techniques were compared for their discriminatory powers in this type of fracture. The results showed that DXA hip and spine had a better discriminatory power in the female vertebral group compared with BUA. In males none of the bone measurements could discriminate between the fracture and non-fracture groups.

Entities:  

Mesh:

Year:  1995        PMID: 7627484     DOI: 10.1259/0007-1285-68-810-614

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

Review 1.  The role of ultrasound in the assessment of osteoporosis: a review.

Authors:  C F Njeh; C M Boivin; C M Langton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men.

Authors:  S F Evans; M W Davie
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

3.  Prediction of fractures in perimenopausal women: a comparison of dual energy x ray absorptiometry and broadband ultrasound attenuation.

Authors:  A Stewart; D J Torgerson; D M Reid
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

4.  Quantitative Ultrasound (QUS) in the Management of Osteoporosis and Assessment of Fracture Risk: An Update.

Authors:  Didier Hans; Antoine Métrailler; Elena Gonzalez Rodriguez; Olivier Lamy; Enisa Shevroja
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.